SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-070190
Filing Date
2023-12-14
Accepted
2023-12-14 06:13:56
Documents
13
Period of Report
2023-12-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alks-20231213.htm   iXBRL 8-K 59871
2 EX-99.1 alks-ex99_1.htm EX-99.1 24036
  Complete submission text file 0000950170-23-070190.txt   215715

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alks-20231213_pre.xml EX-101.PRE 11098
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alks-20231213_lab.xml EX-101.LAB 17886
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alks-20231213.xsd EX-101.SCH 2474
7 EXTRACTED XBRL INSTANCE DOCUMENT alks-20231213_htm.xml XML 4683
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 231485513
SIC: 2834 Pharmaceutical Preparations